Nonrefundable Credit

A nonrefundable Pennsylvania Research and Development tax credit is a statutory fiscal incentive that reduces a taxpayer’s liability dollar-for-dollar but does not permit a cash refund if the credit exceeds the total tax owed. Instead of a direct payment from the Commonwealth, surplus credits are managed through a fifteen-year carryforward provision or converted into liquidity via a regulated secondary market for tax credit assignment.

The Pennsylvania Research and Development (R&D) Tax Credit represents a sophisticated intersection of economic policy and tax law, designed to foster a climate of technological advancement within the Commonwealth. Governed by Article XVII-B of the Tax Reform Code of 1971, this credit functions as a critical mechanism for corporations, pass-through entities, and individuals engaged in scientific and industrial experimentation. Unlike refundable credits, which provide immediate cash infusions to entities regardless of their tax position, the nonrefundable nature of the Pennsylvania R&D credit requires a more strategic approach to tax planning. The limitation to nonrefundability serves as a fiscal safeguard for the Commonwealth, ensuring that the incentive primarily rewards those with an existing or future tax footprint in the state, while the transferability provisions offer a unique market-based refundability that distinguishes Pennsylvania from many other jurisdictions.

Legislative Foundation and Statutory Context

The genesis of the Pennsylvania Research and Development Tax Credit can be traced to Act 7 of 1997, which introduced the incentive to the Tax Reform Code to encourage businesses to increase their research expenditures within state borders. This legislation was codified as Article XVII-B, creating a framework that has since been modified by several significant acts, including Act 46 of 2003, Act 85 of 2016, and Act 53 of 2022. Each legislative update has sought to refine the definitions of eligibility, adjust the annual program caps, or enhance the liquidity of the credits for non-profitable startups.

The statute specifically targets qualified research and development expenses (QREs) incurred for activities conducted within the Commonwealth. By adopting the federal definition of research under Internal Revenue Code (IRC) § 41, the Pennsylvania legislature ensured a level of conformity that simplifies compliance for multi-state entities, while maintaining a strict nexus requirement that the actual work—and the associated costs—must be localized in Pennsylvania.

Key Legislative Milestones

Legislative Act	Year	Primary Impact on R&D Credit
Act 7	1997	Established the R&D Tax Credit under Article XVII-B of the Tax Reform Code.
Act 46	2003	Introduced the ability to sell or assign credits; mandated reporting of awardees.
Act 85	2016	Repealed the sunset provision, making the tax credit a permanent fixture of state law.
Act 43	2017	Authorized the Department of Revenue to perform tax clearances on all applicants.
Act 25	2021	Established a formal appeals process and moved application deadlines.
Act 53	2022	Increased the annual statewide cap to $60 million ($12 million for small businesses).
Act 45	2025	Addressed decoupling from certain federal provisions related to R&D expense amortization.

The Mechanics of Nonrefundability

The core attribute of the Pennsylvania R&D credit is its nonrefundable status, a term that carries specific legal weight in the Pennsylvania Department of Revenue’s (DOR) administrative guidance. A nonrefundable credit is a below-the-line adjustment that reduces the final tax liability calculated on a return. If a taxpayer’s liability is $100,000 and they hold an approved R&D credit of $150,000, the tax liability is reduced to $0. Crucially, the remaining $50,000 does not trigger an automatic refund check from the Department of Revenue.

This mechanism creates a restricted asset. Under Pennsylvania’s Restricted Tax Credit Bulletin 2024-01, these credits are applied to a taxpayer’s account for the tax period open as of the date the credit is approved. They are generally the first credits applied to a liability, which ensures that any cash payments or estimated taxes already paid into the account remain available for transfer or refund, whereas the R&D credit itself remains stuck within the tax system unless there is a liability to absorb it.

Comparison of Federal and State Refundability Profiles

The Pennsylvania credit’s nonrefundability is more rigid than current federal rules for certain small businesses. Under federal law, qualifying startups may use a portion of their R&D credit to offset the employer’s portion of social security taxes (payroll taxes), effectively providing a form of immediate cash relief even in the absence of income tax. Pennsylvania does not currently offer a direct payroll tax offset. Instead, the Commonwealth provides two primary relief valves for the trapped value of nonrefundable credits: the carryforward provision and the sale/assignment program.

Carryover Provisions and the Fifteen-Year Horizon

When a taxpayer cannot utilize the entirety of their R&D credit in the initial year, the statute allows for a fifteen-year carryforward. This period is shorter than the federal twenty-year carryforward but still provides a substantial window for businesses to move from a loss or break-even phase into profitability where the credit can be utilized.

The carryforward logic is governed by a First-In, First-Out (FIFO) methodology. This means that the oldest credits are used first to offset liability, reducing the risk that credits will expire unused at the end of the fifteen-year term.

Carryback Prohibition

A defining characteristic of Pennsylvania’s nonrefundable credit is the absolute prohibition on carrybacks. While federal law allows taxpayers to carry unused R&D credits back one year to recover taxes paid in the previous period, Pennsylvania law explicitly states that a taxpayer is not entitled to carry back or obtain a refund of an unused R&D tax credit. This necessitates a forward-looking tax strategy where the value of the credit is projected against anticipated growth rather than used as a retrospective recovery tool.

Eligibility Criteria and Qualified Research Activities

To benefit from the nonrefundable credit, an entity must first navigate the rigorous eligibility requirements set forth by the DOR. Eligibility is not merely a matter of performing research; it requires a specific legal and fiscal nexus to Pennsylvania.

The Qualified Small Business Distinction

Pennsylvania provides a tiered incentive structure based on the size of the entity. The definition of a small business is critical because it doubles the credit rate from 10% to 20% of the excess QREs.

Business Category	Asset Threshold	Credit Rate (on excess QREs)
Small Business	Net book value of assets < $5 million	20%
Large Business	Net book value of assets ≥ $5 million	10%

The asset threshold is measured at the beginning or the end of the taxable year for which the expenses are incurred, as reported on the balance sheet. For many emerging technology firms, staying under this $5 million net book value is essential for maximizing the credit’s value, though it requires precise accounting of depreciation and asset acquisition.

The Four-Part Test for Qualified Research

Consistent with federal standards under IRC § 41, Pennsylvania requires that all research activities pass a four-part test to qualify for the credit.

1. Technological in Nature: The research must rely on the principles of physical or biological sciences, engineering, or computer science.
2. Permitted Purpose: The research must be intended for the development of a new or improved business component, such as a product, process, software, technique, formula, or invention.
3. Elimination of Uncertainty: The taxpayer must demonstrate that they intended to discover information to eliminate uncertainty concerning the capability, method, or design of the business component.
4. Process of Experimentation: Substantially all of the activities must constitute a process of experimentation, involving the evaluation of alternatives through modeling, simulation, or systematic trial and error.

Revenue Office Guidance on Expenditure Classification

The Department of Revenue provides granular guidance on what expenditures can be included in the calculation of the credit. Because the credit is nonrefundable and subject to proration, accurate classification is essential to avoid application rejection or audit adjustments.

Qualified Pennsylvania Research Expenses (PA QREs)

Eligible expenses are categorized into three primary buckets: wages, supplies, and contract research.

• Wages and Salaries: These include only the direct wages paid to employees for performing, supervising, or directly supporting qualified research. The DOR requires the PA Employer Withholding ID number for all entities where direct wages are reported.
• Supplies and Materials: This category covers tangible property, other than land or improvements to real property, that is consumed or used in the research process. This often includes prototypes and testing components.
• Contract Research Expenses: Taxpayers can include 65% of the amounts paid to third-party contractors for qualified research performed in Pennsylvania. If the research is performed by a qualified organization (such as a university), this may increase to 100% in certain circumstances.
• Computer Rentals/Cloud Costs: The cost of leasing computers or cloud computing platforms for the exclusive purpose of conducting qualified research is eligible.

Excluded Expenditures

Guidance from the DOR and technical bulletins clarify that certain costs are strictly ineligible for the R&D credit. These include:

• Research conducted outside the geographic boundaries of Pennsylvania.
• Routine data collection or quality control testing that does not involve experimentation.
• Market research, consumer surveys, and advertising.
• Capital expenditures for land, buildings, and depreciable equipment.
• Internal software development for routine administrative tasks that do not meet the high threshold of innovation test for internal-use software.

The Application Process and myPATH Integration

The Pennsylvania R&D credit is not claimed directly on a tax return in the first instance; rather, it requires a separate, proactive application to the Department of Revenue. This administrative hurdle is a prerequisite for receiving the award letter that certifies the credit’s value.

Timelines and Deadlines

The application lifecycle is strictly governed by the following calendar:

Milestone	Date	Significance
Application Window Opens	August 1	Taxpayers can begin submitting applications for expenses from the prior year.
Application Deadline	December 1	The final date for all electronic submissions via myPATH.
Departmental Approval	May 1	The date by which the DOR must notify taxpayers of their approved credit.
Issuance of Credits	Following May 1	Credits are applied to the taxpayer’s account and award letters are mailed.

Administrative Requirements via myPATH

The Department of Revenue transitioned the application process to myPATH, its online filing system, to enhance tracking and compliance. A complete application requires:

• Entity Identification: FEIN, Revenue ID, and Corporate Box number.
• Federal Form 6765: A copy of the federal R&D credit form as filed with the IRS, or an equivalent schedule.
• Form REV-545: The specific Pennsylvania R&D credit calculation form.
• Project Descriptions: Detailed answers to the four-part test questions for each Pennsylvania-based project.
• Prior Year Expenditures: Data for at least two (and up to four) prior years to establish the base amount.
• Ownership Disclosure: Identifying all individuals or businesses with a 20% or greater ownership interest.

State Tax Clearance and Compliance Protocols

One of the most significant barriers to obtaining a nonrefundable R&D credit is the tax clearance requirement mandated by Act 43 of 2017. The Department of Revenue performs a comprehensive review of the applicant’s state tax account before any credit is awarded.

Compliance Thresholds

An applicant will be deemed non-compliant and denied the credit if they have outstanding liabilities or unfiled returns in any of the following areas:

• Corporate Net Income Tax (CNIT).
• Employer Withholding Tax.
• Sales and Use Tax.
• Personal Income Tax (for owners of pass-through entities).

This compliance check extends to all 20%+ owners, meaning that the personal tax delinquency of a major shareholder can effectively block a corporation from receiving its R&D credit. The DOR’s stance is that the state will not provide a tax incentive to entities that are failing their basic obligations to the treasury.

Proration and the Statewide Program Cap

The Pennsylvania R&D credit is not an entitlement program; it is a capped incentive. The total pool of available credits is $60 million per year.

The Allocation Formula

If the total amount of qualified credits applied for exceeds the cap, the Department of Revenue must prorate the awards. The $60 million is divided into two distinct buckets:

• $12 Million Set-Aside: Reserved exclusively for qualified small businesses (assets < $5 million).
• $48 Million Remainder: Available for large businesses.

In recent years, the small business pool has been sufficient to cover most or all qualified applications, with small businesses often receiving 100% of their tentative requests. However, the large business pool is consistently oversubscribed. For the most recent program years, large businesses have received approximately 41% to 44% of their tentative awards.

Proration Impact on Tax Planning

The nonrefundable nature of the credit, combined with proration, creates significant uncertainty for tax directors. A large firm that calculates a $1,000,000 credit on its application may only receive an award letter for $440,000. This proration risk means that businesses cannot rely on the full face value of their calculated QREs when making estimated tax payments throughout the year.

Monetizing the Credit: The Sale and Assignment Program

Recognizing that a nonrefundable credit offers little immediate value to a loss-generating technology startup, the Pennsylvania legislature established a mechanism for these credits to be sold. This is governed by the Department of Community and Economic Development (DCED).

The Assignment Process

A taxpayer who has been awarded an R&D credit but has no tax liability to offset can apply to sell or assign that credit to another Pennsylvania taxpayer. This process is initiated using Form DCED-RD-009, the Application to Assign Research and Development Tax Credits.

Requirements for the Seller (Assignor)

• Must have an approved R&D credit issued by the DOR.
• Historically, there was a one-year holding period before a credit could be sold; however, legislative changes removed this for credits awarded in 2003 and later, allowing for immediate sale once the credit is approved.
• Must be in full compliance with all PA state tax laws.
• Must disclose the selling price of the credits to the DCED.
• Can only sell the credit once; once assigned, the seller’s right to the credit is terminated.

Requirements for the Buyer (Assignee)

• Must claim the credit immediately in the taxable year in which the purchase or assignment is made.
• The 75% Limitation: A buyer can only use the purchased R&D credit to offset up to 75% of their qualified tax liability for the year.
• No Carryover for Buyers: If a buyer purchases more credit than they can use (or more than 75% of their liability), the excess credit is lost. It cannot be carried forward to future years.
• No Resale: A buyer cannot resell or reassign the credit to another party.
• Qualified Taxes: The buyer can apply the credit against Personal Income Tax (PIT), Corporate Net Income Tax (CNIT), or Capital Stock and Franchise Tax (CSFT).

The Economics of Selling Nonrefundable Credits

The sale of a nonrefundable credit effectively creates a secondary market where the discount rate reflects the risk and the time value of money. Historically, Pennsylvania R&D credits have sold for between 85% and 93% of their face value. For example, a startup with a $100,000 credit but no tax liability might sell it to a profitable utility company for $90,000 in cash.

The sale is a taxable transaction. The seller must report the proceeds of the sale as income for federal and state tax purposes, while the buyer receives the tax benefit but cannot deduct the purchase price of the credit as a business expense.

Pass-Through Entities and Distributive Share Credits

A significant portion of Pennsylvania’s innovators are organized as S-corporations, Partnerships, or LLCs. For these entities, the nonrefundable credit does not reside at the entity level but must be passed through to the individual owners.

Schedule OC and the Pass-Through Election

Pass-through entities use PA Schedule OC to report and distribute tax credits. The Department of Revenue guidance for pass-through entities is strict:

• Irrevocable Election: The request to pass through a tax credit to an entity owner is irrevocable.
• Proportional Distribution: The credit must be distributed in proportion to the share of the entity’s distributive income to which the owner is entitled.
• Immediate Claim: The owner of a pass-through entity must immediately claim the tax credit in the tax year in which the transfer is made.
• Restriction on Further Transfer: Once a credit has been passed through to a shareholder or partner, that individual cannot carry it forward, carry it back, or sell it.

This creates a high-stakes scenario for S-corps and Partnerships. If the entity passes through $50,000 in credits to a partner, but that partner only has $10,000 in personal income tax liability, the remaining $40,000 is permanently lost. Unlike the entity itself, which could have carried the credit forward for 15 years, the individual owner is restricted to current year use only for credits received via pass-through.

Interaction with Federal Section 174 Amortization

The landscape of the nonrefundable R&D credit changed dramatically with the federal Tax Cuts and Jobs Act (TCJA). Effective for tax years beginning after December 31, 2021, IRC Section 174 required taxpayers to capitalize and amortize R&D expenses over five years (domestic) or fifteen years (foreign), rather than expensing them immediately.

Impact on State Tax Liability

By forcing businesses to capitalize these expenses, the federal government—and consequently Pennsylvania, which couples with federal taxable income for CNIT purposes—increased the taxable income of these companies in the short term. For some companies, this created a significant cash tax burden.

However, the silver lining for the Pennsylvania R&D credit is that the higher taxable income creates a larger tax liability, allowing more companies to utilize their nonrefundable credits immediately rather than carrying them forward or selling them at a discount. This interplay highlights the importance of modeling the credit’s value against the add-backs required by Section 174.

Pennsylvania’s Legislative Response (Act 45 of 2025)

Recognizing the strain Section 174 put on tech companies, the Pennsylvania legislature passed Act 45 of 2025. This law provides a mechanism for taxpayers to claim additional deductions for R&E expenditures that were capitalized under the TCJA, effectively offering a state-level decoupling that eases the cash outlays for Pennsylvania-based researchers.

Audit Defense and Record Retention

Because the R&D credit is a restricted credit, it is subject to high levels of scrutiny from the Department of Revenue’s Bureau of Audits. DOR guidance recommends that taxpayers maintain a contemporaneous record-keeping system.

Essential Documentation for Audit Defense

To protect the validity of a nonrefundable credit, taxpayers must be prepared to provide:

• Time Tracking: Detailed logs or project-based tracking showing the percentage of time each employee spent on qualified research activities in Pennsylvania.
• Technical Evidence: Emails, design documents, white papers, and testing logs that prove a process of experimentation occurred and that technical uncertainties were addressed.
• General Ledger Detail: Invoices and proof of payment for all supplies and contract research costs.
• Nexus Proof: Evidence that the research was physically performed within the state, such as office leases or site-specific project logs.

The DOR reserves the right to perform onsite audits and review these records for up to five years after the application date. If an audit finds that research was not qualified, the credit will be recaptured, and the taxpayer may be liable for interest and penalties.

Comprehensive Illustrative Example: Keystone Robotics Corp

To demonstrate the lifecycle of a nonrefundable Pennsylvania R&D tax credit, consider the case of Keystone Robotics Corp, a specialized software and hardware firm based in Erie, PA.

Phase 1: Expenditure and Application

In 2023, Keystone Robotics incurs $2,500,000 in Pennsylvania-qualified research expenses.

• PA Wages: $1,800,000 (direct engineering and coding)
• PA Supplies: $200,000 (circuit board prototypes)
• Contract Research: $500,000 paid to a Carnegie Mellon University lab (65% included = $325,000; or 100% if structured as a qualified organization grant = $500,000). For this example, we assume 65% utilization: $325,000.
• Total QREs: $2,325,000.

Keystone’s average R&D expenditure over the previous four years (the base amount) was $1,500,000.

• Excess QREs: $825,000 ($2,325,000 – $1,500,000).

Keystone Robotics has $10 million in assets, so it does not qualify as a small business. Its credit rate is 10%.

• Tentative Credit: $82,500 ($825,000 × 0.10).

Keystone submits its application via myPATH by December 1, 2024.

Phase 2: Award and Proration

On May 1, 2025, the DOR notifies Keystone of its award. Because the large business pool was oversubscribed by more than 50%, the proration factor is 44.3%.

• Approved Credit: $36,547 ($82,500 × 0.443).

Phase 3: Utilization against CNIT

Keystone Robotics has a 2024 Corporate Net Income Tax liability of $25,000.

• Credit Applied: $25,000 (reducing liability to $0).
• Unused Credit: $11,547.

Because the credit is nonrefundable, Keystone does not receive the $11,547 in cash. It has three options:

1. Carryforward: Apply the $11,547 to its 2025 tax liability.
2. Sale: Sell the $11,547 to another taxpayer for cash.
3. Pass-Through: If it were an S-Corp, it could pass the $11,547 through to its shareholders.

Phase 4: Monetization via Assignment

Keystone decides to sell the remaining $11,547 to Industrial Steel Co, a large manufacturer in Bethlehem with a $500,000 tax liability.

• Sale Price: Industrial Steel Co pays Keystone $10,392 (90 cents on the dollar).
• DCED Approval: Keystone and Industrial Steel Co file Form DCED-RD-009.
• Buyer Limitation: Industrial Steel Co uses the $11,547 to reduce its liability. Since $11,547 is less than 75% of its $500,000 tax bill, the full amount is utilized.

Transaction Stage	Amount	Outcome
Qualified Spending	$2,325,000	Foundation for credit claim.
Tentative Award	$82,500	Calculated benefit before proration.
DOR Approved Award	$36,547	Actual credit deposited into taxpayer account.
Internal Utilization	$25,000	Dollar-for-dollar reduction of tax.
Sale Proceeds	$10,392	Immediate cash liquidity for the surplus.

Administrative Appeals and Taxpayer Rights

The nonrefundable R&D credit program was historically difficult to appeal until Act 25 of 2021. This act established a formal administrative and judicial appeals process for taxpayers, brokers, and the DOR.

The Board of Appeals Process

If a taxpayer’s application is rejected or their credit amount is significantly reduced due to an expense disqualification (rather than just proration), they can file a petition with the Board of Appeals. Common grounds for appeal include:

• Disputes over whether a specific activity meets the four-part test.
• Disputes over the classification of an employee as a researcher versus administrative support.
• Disagreements regarding the valuation of assets for the small business designation.
• Error in the calculation of the base amount.

Taxpayers must use the DOR’s New Online Petition Center to file these appeals. A successful appeal restores the credit to the taxpayer’s account, but it does not change the statewide program cap; if an appeal is granted after the $60 million has been distributed, the state must find funds from a subsequent year or adjust the proration for all other taxpayers.

Future Outlook and Strategic Considerations

The Pennsylvania R&D credit remains a cornerstone of the state’s economic development strategy, but it is a living program subject to the fluctuations of the state budget and federal tax shifts.

Potential Legislative Expansions

There is significant advocacy from the technology community to increase the $60 million cap. With tentative awards often exceeding $130 million annually, many large companies feel the current 44% proration dilutes the incentive’s effectiveness. Furthermore, discussions regarding a refundable option for the state’s smallest startups continue, as the current sale/assignment process, while effective, still imposes a 10-15% liquidity tax in the form of the buyer’s discount and broker fees.

Strategic Integration for Corporate Peers

For tax professionals, the nonrefundable R&D credit must be managed as part of a holistic state tax strategy. Key recommendations include:

• Proactive Compliance: Resolve all minor tax notices immediately to ensure the tax clearance hurdle does not block the December 1 application.
• Small Business Asset Management: If an entity is close to the $5 million net book value threshold, acquisitions and depreciation schedules should be reviewed to see if the 20% credit rate can be secured.
• Secondary Market Timing: Sellers should engage with brokers early in the award cycle (May-June) to find buyers and secure the highest possible price for their credits.
• Nexus Documentation: As the DOR increases its use of onsite audits, maintaining a physical Pennsylvania Research Binder with technical and financial evidence is no longer optional—it is a requirement for credit defense.

The nonrefundable Pennsylvania Research and Development tax credit serves its dual purpose: it encourages permanent, high-value investment in the Commonwealth’s industrial and technological base while protecting the state’s fiscal solvency. Through the innovative mechanism of credit assignment, the state has effectively decoupled the incentive from the immediate need for profitability, ensuring that Pennsylvania remains a competitive hub for the innovators of tomorrow.